Legal Representation
Attorney
Cheryl A. Withycombe
USPTO Deadlines
Next Deadline
135 days remaining
NOA E-Mailed - SOU Required
Due Date
May 05, 2026
Extension Available
Until November 05, 2026
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 5, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 5, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 4, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 22, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 21, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 21, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 21, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 18, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Apr 18, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 18, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 18, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 18, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 18, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 5, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 21, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 6, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 2, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 2, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 2, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 12, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 12, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 12, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 30, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 30, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 30, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 29, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 29, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 29, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 29, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 1, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceuticals and therapeutic pharmaceuticals for the treatment of neurological conditions; pharmaceuticals and therapeutic pharmaceuticals for the treatment and prevention of immunological conditions; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer; pharmaceuticals and therapeutic pharmaceuticals for the treatment and prevention of ophthalmic conditions
Class 042
providing a biotechnology platform, namely, providing scientific research and development, to enable drug developers to enhance structure of proteins and antibodies for use in the treatment of neurological conditions and cancer, for use in the treatment and prevention of immunological conditions and ophthalmic conditions; research and development of therapeutics for others
Classification
International Classes
005
042